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Abstract
Persistence of effector cytotoxic T lymphocytes (CTLs) during an immunological response is
critical for successfully controlling a viral infection or tumor growth. Various cytokines are known
to play an important part in regulating the immune response. The IL-2 family of cytokines that
includes IL-2 and IL-15 are known to function as growth and survival factors for antigen-
experienced T cells. IL-2 and IL-15 possess similar properties, including the ability to induce T
cell proliferation. Whereas long term IL-2 exposure has been shown to promote apoptosis and
limit CD8+ memory T cell survival and proliferation, it is widely believed that IL-15 can inhibit
apoptosis and helps maintain a memory CD8+ T-cell population. However, mechanisms for
superior outcomes for IL-15 as compared to IL-2 are still under investigation. Our data shows that
human T cells cultured in the presence of IL-15 exhibit increased expression of anti-oxidant
molecules Glutathione reductase (GSR), Thioredoxin reductase 1 (TXNDR1), Peroxiredoxin
(PRDX), Superoxide dismutase (SOD). An increased expression of cell-surface thiols,
intracellular glutathione, and thioredoxins was also noted in IL-15 cultured T cells. Additionally,
IL-15 cultured T cells also showed an increase in cytolytic effector molecules. Apart from
increased level of Granzyme A and Granzyme B, IL-15 cultured T cells exhibit increased
accumulation of reactive oxygen (ROS) and reactive nitrogen (RNS) species as compared to IL-2
cultured T cells. Overall, this study suggests that T cells cultured in IL-15 show increase
persistence not only due to increased anti-apoptotic proteins but also due to increased anti-oxidant
levels, which is further complimented by increased cytolytic effector functions.
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1. Introduction
Expansion of the CTL population and maintenance of its long-term functional activity is
central to the success of T cell immunotherapy [1]. Various strategies are being developed to
increase T-cell persistence to control tumor growth or viral infections [2-5]. To this end, the
role of cytokines in maintaining T cells growth is well known and has been widely exploited
in T-cell immunotherapy [6-7]. In fact, immunotherapy protocols employing IL-2 as a T-cell
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growth/activation factor have been used extensively for treating patients with metastatic
melanoma and renal cell carcinoma [6, 8]. IL-15, a member of the same cytokine family as
IL-2, is considered to be more efficacious than IL-2 in immunotherapy regimens [7, 9-12],
but the mechanisms for this increased efficacy are still under investigation [11, 13-14].
An important aspect of increased efficacy of IL-15 as compared to IL-2 is attributed to its
anti-apoptotic activity, enhancing the survival of effector and memory CD8+ CTLs [15-18].
Earlier studies suggest that despite the differences in anti-apoptotic protein bcl-xl expression
IL-15 equally promotes the survival of CD8+ T cells with both naïve and activated
phenotype as determined by expression of CD44 – an adhesion molecule that is expressed at
low levels in naïve and at high levels in activated T cells [19]. Thus, the mechanism how
IL-15-mediated rescue from T-cell apoptosis occurs is not completely understood. Here, we
show that IL-15 pretreated T cells have higher level of free sulfhydryl groups (-SH; also
referred as thiol) on cell surface and intracellular glutathione (iGSH) compared to IL-2
treated T cells. Increase in these key anti-oxidants are accompanied by elevated thioredoxins
(Trx) in IL-15 treated cells irrespective of the phenotype. Interestingly, an evaluation of
antioxidant and oxidative stress related genes on T cells cultured in the presence of IL-15 vs.
IL-2 revealed that IL-15 induced up-regulation of 11 genes whereas 8 genes were down-
regulated. Further our data also suggests that when T cells cultured in presence of IL-15
were compared to the ones cultured in IL-2 an increase in expression of cytolytic proteins
Granzyme A, Granzyme B as well as increased accumution of reactive oxygen (ROS) and
nitrogen species (RNS) upon restimulation was observed. Thus, while increased antioxidant
level in T cells cultured with IL-15 could protect against oxidative stress-induced cell death,
a concomitant increase in cytolytic molecules support the increased effector function.
2. Materials and Methods
2.1. Cells, culture medium, and reagents
Peripheral blood mononuclear cells (PBMC) from healthy donors were obtained after
approval by institutional review board from a commercial vendor Research Blood
Components, LLC (Brighton, MA, USA). Culture medium was Iscove’s Modified
Dulbecco’s Medium (GIBCO BRL, Grand Island, NY) supplemented with 10 % fetal
bovine serum (Gemini Bioproducts Inc., Calabasas, CA). Ficoll-Paque was obtained from
Amersham Bioscience (Piscataway, NJ). Recombinant cytokines were purchased from R &
D Systems (Minneapolis, MN).
2.2. Hydrogen peroxide mediated cell death
Hydrogen peroxide (H2O2) was used to mimic conditions of oxidative stress as described
previously [20]. T cells obtained from PBL and expanded in the presence of either IL-2 (100
IU/ml) or IL-15 (10 ng/ml) were cultured with different concentrations (5–200 μM) of H2O2
for 24–48 hrs. Using a flow cytometry-based method, cell death measurements were
performed by staining for Annexin V according to the manufacturer’s protocol (BioVision,
Mountain View, CA) and acquired on a FACSCalibur (Becton Dickinson, Mountain View,
CA) or an Accuri C6 (Accuri Cytometers, Ann Arbor, MI) flow cytometer. Data was
analyzed using FlowJo software (Tree Star Inc., Ashland, OR).
2.3. Western blot
Protein extractions were performed in RIPA buffer and samples were separated on 15% SDS
polyacrylamide gels and electrophoretically transferred to nitrocellulose membranes
(Millipore, Burlington, MA) as described earlier [21]. The primary antibodies (anti-Trx,
anti-GAPDH) and secondary antibodies were obtained from Cell Signaling Technology
(Danvers, MA) or Santa Cruz Biotechnology, (Santa Cruz, CA).
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2.4. Staining for intracellular GSH and surface thiols
Intracellular GSH was evaluated using Monochlorobimane (MCB) staining with slight
modification as described earlier [22-23]. Monochloromobimane is essentially non-
fluorescent until conjugated, readily reacts with low molecular weight thiols. Briefly, 1-2 ×
106 cells were stained with 40 μM MCB (Molecular Probes, Eugene, OR) in ice for
precisely 15 min that forms the blue fluorescent adduct with iGSH. Cells were chilled by
addition of ice-cold FBS at 0°C to stop the enzyme dependent staining reaction. Cells were
then washed and maintained at 4°C during the remaining treatments. 2.5 mM Probenecid
was added to the staining medium to prevent outflow of the fluorescent MCB conjugate
(GSB) during the MCB staining step and thereafter. Cells were excited with a UV 405 nm
laser, and emission was acquired with a 440/40 filter.
To stain cell surface thiols, Alexa Fluor® 633 C5 maleimide dye (ALM) (Invitrogen,
Carlsbad, CA) was used. Alexa dyes coupled to maleimide (ALMs) do not interfere with the
efficieny of the maleimide-thiol reaction. They are charged molecules, do not enter cells and
can be detected by FACS and reveal the overall thiol levels present on the cell surface.
Briefly, 1-2 × 106 cells were washed with 1X PBS, and 1 μM ALM was added in cell
suspension and incubated for 10 min on ice. Cells were then extensively washed and kept at
4°C.
2.5. Measurement of mitochondrial membrane potential (Δψ)
Δψ was estimated by staining with 20 nmol/L 3,3′-dihexyloxacarbocyanine iodide (DiOC6)
(Molecular Probes, Eugene, OR), a cationic lipophilic dye, for 10 min at 37°C in the dark
before analysis by flow cytometry. Fluorescence of DiOC6 is oxidation independent and
correlates with Δψ [24].
2.6. Determination of intracellular reactive oxygen species (ROS)
Dihydroethydium (DHE) (Sigma Aldrich, USA), 5-(and -6) carboxy -2 ′ , 7 ′-
dichlorodihydrofluorescein diacetate (Carboxy-H2DCFDA) (Molecular Probes, Eugene,
OR), an ROS sensitive dyes, were used to evaluate the intracellular ROS level. T cells were
stained with HE (1 μM) or CMH2-DCFDA (10 μm) for at 37°C for 10 min. The
intracellular ROS were measured by flow cytometry. At least 10,000 cells were analyzed in
each group using FACScalibur (BD Instruments, Mountain View, CA).
2.7. Intracellular nitric oxide (NO) determination
T cells were loaded with Diacetate (4-amino -5 methylamino- 2′, 7′- difluorescein
diacetate) (DAF-FM) (1 μm; Molecular Probes, Eugene, OR) and incubated (10 min, 37°C)
in the dark. Care was taken to prevent exposure to light throughout the rest of the
experimentation, as the probe is light sensitive. After incubation with DAF-FM, the cells
were analysed by flow cytometry. At least 10,000 cells were analyzed.
2.8. Total RNA Extraction and Reverse Transcription
T cells cultured and maintained in the presence of IL-2 and IL-15 from three different
donors for 10 days. 5×106 cells from each treatment were pellet down and total RNA was
isolated by TRIzol (Invitrogen, Carlsbad, CA) Reagent method. Reverse transcript (the
cDNA) was synthesized from 2.5μg total RNA using iScript cDNA Synthesis Kit
(SABiosciences Corp, Frederick, MD). Reverse transcript PCR quantification was
performed. Briefly, 50μl reaction mix contained: cDNA, 10X PCR buffer, dNTPs, Taq
DNA polymerase and primers at final concentration of 20 μM. The sequences of the primers
used for RT PCR are bcl-2 (forward, 5′-GGAGGATTGTGGCCTTCT-3′; reverse, 5′-
GTTATCCTGGATCCAGGTGT-3′), bcl-xl (forward, 5 ′-
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CTTGGATGGCCACTTACCTGA-3′; reverse 5 ′-TCTTCTGGTCATTTCCGACTGAAG),
iNOS (forward, 5′-GTTCTCAAGGCACAGGTCTC-3 ′ ; reverse 5 ′-
GCAGGTCACTTATGTCACTTATC-3 ′ ) T-bet (forward, 5 ′-
CCCCCAAGGAATTGACAGTTG-3 ′ ; reverse 5 ′-
GGGAAACTAAAGCTCACAAAC-3′), GAPDH (forward, 5 ′-
GAAGATGGTGATGGGATTTC-3 ′ ; reverse 5′-GAAGGTGAAGGTCGGAGTC -3′).
PCR products were separated by 1% agarose gel.
2.9. Real Time PCR-Based Array Analysis
The relative expression of genes involved in oxidative stress was determined in each of the
four RNA samples from two different donors treated with IL-2 or IL-15 alone for 7 days
using an RT2 Profiler™ Human Oxidative Stress and Antioxidant Defense PCR Array (Cat.
No. PAHS-065, SABiosciences Corp, Frederick, MD) that profiles the expression of 84
genes related to oxidative stress. Equal amounts of total RNA from each sample were
reverse transcribed to form cDNA. Samples were diluted in RT2 SYBR® Green qPCR
master mix according to the supplier’s directions and pipetted into 96-well PCR array plates
to evaluate the expression of 84 oxidative stress and antioxidant defense related genes. Real-
time PCR was performed in technical duplicates using a Bio Rad iCycler Detection System.
Raw data from the real-time PCR was uploaded using the RT2 Profiler PCR Array Data
Analysis Template available at SABiosciences web site. Quality controls included within the
array plates confirmed the lack of DNA contamination and successfully tested for RNA
quality and PCR performance. The integrated web-based software package for the PCR
array system automatically performed all comparative threshold cycle based fold-change
calculations from the up-loaded data. For these calculations, the average expression of three
housekeeping genes (hypoxanthine, beta-actin and ribosomal protein L13a) was used for the
normalization of the data. After normalization, the relative change in the expression of each
gene ≥ 2-fold in IL-15 treated cultures to that of IL-2 from two different donors was
considered to be significant.
3. Results
3.1. Effect of IL-2 and IL-15 on T-cell apoptosis
Human T cells were cultured with IL-2 and IL-15 for 7 days to evaluate the effect of IL-2
and IL-15. Our data indicate that oxidative stress-mediated apoptosis induced by H2O2 was
more prominent in T cells cultured with IL-2 than in those cultured with IL-15 (Figure 1A).
These results are similar to those shown by earlier studies highlighting anti-apoptotic
characteristic of IL-15 [25-27]. However, we reasoned that for an oxidative agent such as
H2O2 to induce cell death differentially, differences must exist in reduced or oxidized
surface molecules/proteins which could correlate to the cytokines used for pretreatment and
hence the difference in susceptibility to H2O2-mediated apoptosis. Because recent studies
have implicated reduced thiols (cysteine –SH) in the function of individual cell surface
proteins [28-29], we evaluated the level of cell surface thiols (cs-SH) on T cells cultured in
IL-2 and IL-15 using fluorochrome conjugated melamide dye as described earlier [29]. Our
data show that CD8+ T cells cultured in IL-15 had more cs-SH expression compared to those
cultured in IL-2 (Figure 1B). Importantly, a dose-response analysis performed after culturing
CD3+ T cells in the presence of increasing concentrations of IL-15 revealed a linear increase
in cs-SH (Figure 1C), thereby favoring a direct role of IL-15 in regulating T cell thiols. It
has also been documented that overall cs-SH content on cell surface molecules could be
correlated to the level of intracellular glutathione (iGSH) [30]. Measuring iGSH on CD8+ T
cells using the monochlorobimane staining [28] revealed higher expression of this key anti-
oxidant molecule in cells cultured in the presence of IL-15, as opposed to cells cultured in
the presence of IL-2 (Figure 2A). A further evaluation of Thioredoxins (Trx), proteins that
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acts as antioxidant by facilitating the reduction of other protein by cysteine thiol-disulfide
exchange [31], revealed increased in mitochondria specific Trx-2 in T cells cultured with
IL-15 (Figure 2B). These data suggest that increased level of reduced –SH groups and iGSH
after IL-15 treatment could be responsible for the increased ability of T cells to persist in a
tumor-induced oxidative stress microenvironment. Next we investigated whether these
protective effects of IL-15 could be due to the differential expression level of genes involved
in oxidative stress and ROS metabolism.
3.2. Expression of Oxidative stress and antioxidative defense related genes
A Real time PCR-based array was used to compare the relative expression of 84 oxidative
stress and antioxidant defense related genes in IL-2 and IL-15 expanded T cell cultures from
two different HLA-A2-positive healthy donors. Data from the IL-15 culture was then
compared with that from the IL-2 culture. A relative change in expression of genes ≥ 2 fold
was considered to be significant. As detailed in Table 1 of the 84 genes tested, 19 were
uniquely differentially expressed (11 over-expressed and 8 under-expressed). Genes that
were significantly overexpressed included FOXM1 (Forkhead box M1), GSR (Glutathione
reductase), MLT5 [Metallothionein-like 5, testis-specific (tesmin)], NUDT1 Nudix
(nucleoside diphosphate linked moiety X)-type motif 1, IPCEF1 (Interaction protein for
cytohesin exchange factors 1), PRDX1 (Peroxiredoxin 1), PRDX2 (Peroxiredoxin 2), SIRT2
[Sirtuin (silent mating type information regulation 2 homolog)2 (S. cerevisiae)], SOD1
(Superoxide dismutase 1, soluble), SOD2 (Superoxide dismutase 2, soluble) and TXNRD1
(Thioredoxin reductase 1). Genes that were significantly under-expressed in IL-15 cultures
included CYGB (Cytoglobin), DUSP1 (Dual specificity phosphatase 1), MPO
(Myeloperoxidase), NOX5 (NADPH oxidase, EF-hand calcium binding domain 5), PRG3
(Proteoglycan 3), PTGS2 [Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H
synthase and cyclooxygenase)], PXDNL [Peroxidasin homolog (Drosophila)-like], TPO
(Thyroid peroxidase), TXNDC2 [Thioredoxin domain containing 2 (spermatozoa)]. After
individually confirming the Real-Time PCR results of key anti-oxidant molecules that were
up-regulated in presence of IL-15 we then investigated its ability to modulate anti-apoptotic
and cytolytic molecules in T cells.
3.3. Induction of anti-apoptotic and cytolytic protein expression following IL-15 stimulation
While we uncovered the novel role of IL-15 in up-regulating the antioxidant capacity of a T
cell we wanted to confirm the role of IL-15 in up-regulating anti-apoptotic protein as has
been shown earlier [32]. Thus, T cells were expanded from PBMC of healthy donors in the
presence of IL-2 or IL-15 for 7 days. Total RNA was isolated and mRNA expression of key
anti-apoptotic molecules bcl-2, bcl-xl and Th1 transcription factor T-bet along with
cytokines IFN-γ and TNF-α was assessed. Our data showed that cells cultured in the
presence of IL-15 exhibit elevated levels of bcl-2 and bcl-xl as evaluated both by flow
cytometery and RT-PCR (Figure 3Ai & Figure 3Aii). Similarly, increased transcripts for T-
bet, a Th1-specific T box transcription factor that controls the expression of Th1 cytokine
[33] was noted in T cells cultured in presence of IL-15 as compared to IL-2. Additionally,
IFN-γ and TNF-α transcripts were also found to be elevated in IL-15 cultures (Figure 3B).
Increased cytokine secretion from T cell cultured in IL-15 was also accompanied by
increased cell surface expression of CD44 – a widely expressed adhesion receptor that is an
indicator of a previous immune response and elevated on the surface of memory T cells
[34]. In addition, a comparison of T cells cultured in IL-15 vs. IL-2 showed reduced
expression of CD57 - a marker for replicative senescence and immune deficiency on IL-15
cultured derived T cells (Figure 3C) [35]. The expression levels of CD44 and CD57 on
CD8+ T cells obtained after in vitro expansion with IL-15 supports the fact that IL-15 results
in increased persistence and higher cytokine accumulation upon re-stimulation [36].
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To further compare the effect of IL-15 vs. IL-2 on cytolytic capacity of T cells we evaluated
the expression levels of cytolytic molecules using flow cytometry. We observed that CD8+
T cells when cultured and maintained in IL-15 exhibits higher expression of Granzyme A
and Granzyme B as compared to IL-2 (Figure 3D). The expression of Granzyme A and
Granzyme B was not detected in fresh isolated CD8+ T cells (data not shown). The above
data confirms that IL-15 promotes antigen independent in vitro expansion, promotes level of
cytolytic molecules and long-term survival of cytotoxic T lymphocytes [37-39]. Since, IL-15
has been recently shown to possess innate anti-tumor activity independent of NK and CD8+
T cells [40] we further examined the potential of IL-15 cultured T cells in contributing to
ROS accumulation and innate immunity [41].
3.4. Effect of IL-15 on Reactive Nitrogen Species (RNS) and Reactive Oxygen Species
(ROS)
Reverse transcription PCR-based analysis for inducible nitric oxide synthase (iNOS) showed
elevated levels of iNOS (Figure 4A) in cells obtained from culture maintained in IL-15 than
in IL-2. We further tested if increased iNOS expression in IL-15 cultured T cells results in
increased generation of NO and other free radical moieties in CD8+ T cells using flow
cytometry. T cells expanded and maintained in IL-2 and IL-15 cytokine were activated with
different stimuli: anti-CD3 for TCR engagement, H2O2 for oxidative stress,
Phytohaemagglutinin – a lectin, and Staurosporine - a general kinase inhibitor. Our data
shows that IL-15 cultured T cells showed increase generation of NO as measured by
Diacetate (4-amino -5 methylamino- 2′, 7′-difluorescein diacetate) (DAF-FM) using flow
cytometry (Figure 4B). Since, free radical are cytolytic and could result for increased overall
cytolytic ability of a T cell we further compared the level of other reactive oxygen species
between IL-15 vs. IL-2 cultures. Our data shows that T cell cultured in presence of IL-15
showed increase generation of superoxide and hydrogen peroxide as measured by
Dihydroethidium (DHE) (Figure 4C) and 5-(and -6) carboxy -2′, 7′-
dichlorodihydrofluorescein diacetate (DCFDA) staining respectively (Figure 4D). Further,
evaluation of mitochondrial membrane potential – a hallmark of apoptosis – shows that
under different conditions of stimulation tested the T cell cultured in presence of IL-15
maintained membrane integrity better than IL-2 cultured T cells (where an increased loss of
membrane potential was noticeable) (Figure 4E). These results indicate that IL-15 play an
important role in inducing cytotoxic activity through free radical induction while avoiding
apoptosis.
4. Discussion
The immune system is primarily dedicated to the maintenance of innate and adaptive
immunity via the involvement of various immune mediators (as cytokines, chemokines etc.)
or through executioner cells (as T, B, NK cells etc). Some degree of redundancy in the
function of various cytokines or the lymphocyte population exists; however, the mechanisms
for such observations are unclear. For the IL-2 family of cytokines, which includes IL-2 and
IL-15, this redundancy can be explained by the sharing of the common receptor subunits.
However, distinct actions of IL-2 and IL-15 in AICD and in the survival of memory
phenotype CD8+ T cells have been highlighted [11]. Although IL-2 is an important growth
and survival factor, it also plays a pivotal role in AICD [18, 42]. IL-15, in contrast, extends
the survival of lymphocytes by acting as a growth factor and by inhibiting IL-2-mediated
CD4+ T cell AICD [16]. The mechanism underlying AICD inhibition by IL-15 has not been
completely defined. Our data show that, in addition to increased bcl-2 and bcl-xl, IL-15
confers protection against apoptosis by increasing the anti-oxidant capacity of T cells as
indicated by increased cell surface thiol, iGSH in an antigen independent manner in T cells.
This data is in line with earlier reports of an equivalent effect of IL-15 on both naïve and
Kaur et al. Page 6
Cytokine. Author manuscript; available in PMC 2013 March 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
memory T cells [19]. The IL-15-mediated increase in thiols that protect cells from reactive
oxygen species (ROS) and imparts an antioxidant capacity is also supported by over-
expression of several antioxidant defense related genes as mentioned in Table 1.
Importantly, the increased anti-oxidant capacity in the presence of IL-15 attributed to the
increased expression of thiols is novel. The thiol levels can be manipulated in vitro by
altering iGSH [30]. iGSH, a cysteine-containing tripeptide (γ-glutamylcysteinylglycine),
and its oxidized dimer GSSG, have key roles in regulating the intracellular redox balance
and the status of -SH groups on proteins and other molecules [43]. Results of the real-time
PCR based array provide the evidence that levels of gluthathione reductase (GSR),
peroxiredoxin 1 (PRDX1) and peroxiredoxin 2 (PRDX2) were increased in the presence of
IL-15 as compared to IL-2. Interestingly, superoxide dismutase-1 (SOD1), superoxide
dismutase-2 (SOD2) and sirtuin 2 (SIRT2) levels were also elevated in IL-15 cultures. The
enzyme GSR is essential for the functioning of reduced glutathione (GSH). GSR catalyzes
the reaction that converts oxidized glutathione (GSSG) to GSH using NAD(P)H as an
electron donor [44]. GSR plays a key role in response to oxidative stress by maintaining the
intracellular pool of GSH. Upregulated GSR levels protect cell mitochondria from thiol
oxidative-stress induced injury, thereby preventing dysfunction or cell death [45]. Similarly,
the expression of SIRT2 - a member of a highly conserved gene family (sirtuins) encoding
nicotinamide adenine dinucleotide (NAD)(+)-dependent deacetylases - that function as a
deacetylase for numerous protein targets involved in various cellular pathways, including
stress responses, apoptosis was found to be upregulated in presence of IL-15 than IL-2. We
also observed an up-regulation of Prdx-1 and Prdx-2 in IL-15 cultures. Prdxs are antioxidant
enzymes that have peroxidase functions and are found in both the cytoplasm and nucleus
and work with thioredoxin-1 to effectively detoxify hydrogen peroxide (H2O2). In addition,
elevated Thioredoxin (Trx) and Thioredoxin reductase1 (TXNRD1) expression supports our
observation that IL-15 increases anti-oxidant capacity of T cells. Trx are a vital component
of the thiol-reducing system and regulate various cellular functions (redox regulation)
[46-47]. Members of the Trx system regulate apoptosis through a wide variety of
mechanisms. Previous studies have shown that mitochondrial Trx-2 is essential for cell
viability and plays a crucial role in the scavenging ROS in mitochondria and in regulating
the mitochondrial apoptosis signaling pathway [48]. TXNRD1 are a family of selenium-
containing pyridine nucleotide-disulphide oxidoreductases with mechanistic and sequence
identity to glutathione reductases. TrxRs catalyse the NADPH-dependent reduction of the
redox protein thioredoxin (Trx), as well as of other endogenous and exogenous compounds
[49]. TXNRD1, either alone or in combination with Trx, has also been shown to interact
with apoptosis signal-regulating kinase 1 (ASK-1). Thus, this system is also a sensor of
oxidative stress [50] and involved in various cellular processes, including proliferation,
apoptosis and differentiation. In fact, recent progress in the understanding of the cellular
function of the TXNRD1 and Trx systems has focused on the regulatory roles of these
enzymes in ROS-mediated signalling [51]. The expression levels of Nudix (nucleoside
diphosphate linked moiety X) type motif 1 (NUDT1) were higher in the presence of IL-15.
This is an antimutagenic gene, encodes for an enzyme that can hydrolyze 8-oxo-dGTP to 8-
oxo-dGMP NUDT1 [52], thereby preventing the mis-incorporation of 8-oxo-dGTP
produced by reactive oxygen species normally formed during cellular metabolic processes.
The expression of Forkhead box M1 (FOXM1) was also found to be elevated in IL-15
cultures. FOXM1 is known to accelerate cell entry into S phase and mitosis and earlier
expression of genes involved in cell cycle progression and proliferation.
On the other hand, Real-time PCR based array data also showed that NADPH oxidase, EF-
hand calcium binding domain 5 (NOX5) expression was decreased in the presence of IL-15
by 4.19-fold in comparison with IL-2. NOX enzymes reduce molecular oxygen to
superoxide that can be further converted to various secondary ROS. Since several factors
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other than Nox family of enzymes control the generation ROS [53] - efforts are underway to
identify Nox independent molecules that control ROS generation in IL-15 cultured T cells.
Further, we noticed that expression of, PTGS2, also known as cyclooyygenase-2 (COX-2); a
well-characterized enzyme that contributes to the inflammatory process was 3.40-fold
downregulated in IL-15 culture. The other most significantly down regulated genes
identified by the PCR-based array were Cytoglobin (−19.25), Dual specificity phosphatase 1
(−11.06), Myeloperoxidase (−16.76), Proteoglycan 3 (−5.53) and Thyroid peroxidase
(−3.17). Dual specificity protein phosphatase 1 (DUSP-1), also known as MKP-1 can
dephosphorylate MAP kinases, terminate MAP kinase-regulated gene transcription [54].
MKP-1/DUSP1 also acts as negative regulator of cellular proliferation. Our data shows that
IL-15 could inhibit DUSP-1/MKP-1 and effect cell viability and function. The other
molecule found to be down regulated was myeloperoxidase (MPO). MPO is an enzyme that
is primarily found in neutrophils and monocytes/macrophages. Intracellularly, it plays a
major role in microbial killing, but extracellularly, it may cause host tissue damage [55]. An
earlier study suggested that MPO could serve as a sensitive predictor for myocardial
infarction in patients presenting with chest pain and elevated MPO levels predict more than
doubled the risk for cardiovascular mortality [56]. A recent study has also suggested the
differential expression of MPO on T cells and showed that MPO gene expression was
greater in CD62L− vs. CD62L+ memory CD4+ T cells [57]. Since IL-15 is also known to
preserve CD62L expression and promotes central memory phenotype [58] our data
highlights another important attribute of IL-15, i.e. modulate antioxidant molecules to
increase persistence. Thyroid peroxidase (TPO) is a type of enzyme produced in the thyroid
involved in iodination that occurs via reactive iodine species released from TPO. Higher
levels of TPO are common in those with Graves’ disease and Hashimoto’s disease. Earlier
studies have isolated the TPO Specific T Cell Clones from patients with Hashimoto’s
thyroiditis (HT) and implicated in its pathogenesis [59]. Since increased circulating pro-
inflammatory cytokines and Th17 lymphocytes have been implicated in Hashimoto’s
thyroiditis [60], a reduced expression of TPO and other inflammatory genes as COX-2
points to a possible role for IL-15 in controlling autoimmunity. Another important molecule
that was down regulated in presence of IL-15 was PRG3 - a p53-inducible apoptogenic gene
- that encodes a homologue of the apoptosis-inducing factor (AIF), a well-characterized
mitochondrially released factor [61]. Redox regulation represents a fine balance between
generation and scavenging of ROS by pro- and antioxidant pathway. Our observation that
IL-15 results in significant up-regulation of antioxidant proteins such as Prdx, Trx, SOD,
Sirt2, GSR, Nudix, while down-regulating the expression of pro-oxidant molecules like
Nox, Cox, TPO, MPO implicates IL-15 as an important redox regulator and tilts the balance
in favor of its role as cytokine promoting antioxidant levels. Thus, the PCR based array data
supports the anti-apoptotic role of IL-15 and identifies novel anti-oxidant genes that are also
modulated by IL-15.
While we report a novel role of IL-15 in controlling the anti-oxidant capacity of T cell we
also confirmed that IL-15 affects bcl-2 family proteins. Several studies have invoked a role
for bcl-2 in protection from ROS-induced apoptosis; the mechanism(s) by which bcl-2
prevents ROS-induced apoptosis is unknown. Anti-apoptotic bcl-2-like proteins do not
themselves possess antioxidant enzymatic activity [62-63]. However, several studies have
suggested that bcl-2 over expression can enhance the levels or redistribution of glutathione
within cells [64-67] and modulate the release of apoptogenic factors, such as cytochrome c
and apoptosis-inducing factor, from mitochondria. Further, anti-apoptotic effect of bcl-xl has
also been attributed to the regulation of GSH homeostasis by preventing GSH loss [68]. In
addition, long-term bcl-2 over expression induces the up regulation of superoxide dismutase
(SOD)[65]. Thus, overexpression of bcl-2 may allow cells to cope better with the effects of
ROS, possibly by allowing increases in endogenous antioxidant enzymes. We also examined
that the cells cultured in the presence of IL-15 showed elevated levels of bcl-2, bcl-xl and
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SOD - the first line of defense against superoxide radicals to form H2O2 and oxygen. These
results are in agreement with previous studies which have shown that IL-15 inhibits the
apoptosis of HIV-specific CD8+ T cells [69-70] and induces both bcl-2 and bcl-xl levels in
these cells, suggesting the up-regulation of these antiapoptotic molecules might be corealted
to the upregulation of intracellular glutathione - a potential mechanism by which IL-15 acts
to inhibit apoptosis of these cells.
Our data also show that the IL-15 treated CD8+ T cells with more thiols had increased
activity of T-bet. Up regulated Th1 transcription factor T-bet signifies active transcription of
the cytokine genes [71] and correlates to increased cytokine levels in T cells. Additionally,
IL-15 also induced the expression of iNOS and lead to higher production of NO upon
exposure to different stress stimuli. The results are in agreement with a recent report where
IL-15 was shown to enhance the production of NO by overexpression of iNOS to mediate
antitumor activity [40]. Further, we found that CD8+ T cells cultured and maintained in the
presence of IL-15 attained increased levels of intracellular Granzyme A and Granzyme B
expression to maintain cytolytic activity in comparison to IL-2 treated cultures. This finding
extends the previous observations where IL-15 was found to induce Granzyme B and lytic
capacity of CD8+ T cells in the absence of antigen and TCR stimulation [39]. Further, our
data shows that CD8+ T cells cultured in the presence of IL-15 maintained their
mitochondrial membrane integrity (as shown by DiOC6 staining) as compared with IL-2
cultures upon activation. Mitochondrial membrane permeability changes are accompanied
by release of various proteins from the inter-membrane space that initiate and maintain a
caspase cascade, chromatin condensation, and DNA fragmentation. Release of these proteins
results in permeabilization of the inner mitochondrial membrane and dissipation of Δψ [72].
The elevated levels of anti-apoptotic bcl-2 and bcl-xl proteins in presence of IL-15 could be
implicated in conserving the mitochondrial membrane potential in T cells, since these
molecules have been shown to target the permeability transition pore complex of the
mitochondrial membrane. In addition, our data showed an increased accumulation of ROS
and RNS as tracked using intracellular stains and flow cytometry [24, 73-74]. These results
indicate that IL-15 play an important role in inducing cytotoxic activity through free radical
induction and maintenance of anti-oxidative properties by over-expression of key anti-
oxidant genes as Trx, Sirt2, SOD1 and SOD2 in T cells when compared with IL-2. Thus, it
is likely that the reduced extent of death and increased cytolytic effect of T cells in IL-15
cultures found in our experiments could be attributed to the homeostatic balance between
oxidative stress and anti-oxidant defense related machinery.
While our results can be potentially important in adoptive transfer protocols where IL-15
instead of IL-2 could be used to enhance tumor specific cytotoxicity there still exists an in
vivo scenario where T cells will likely encounter a mixture of cytokines that can either
synergize to augment T cell function [75] or antagonize to inhibit T cell function [76].
Therefore, further studies to address the role of cytokines as redox regulators will be
important. However, we conclude that ’redox remodeling’ [77] could be an important
immunoregulatory strategy and identification of factors (cytokines or pharmacological
compounds) [5, 78-84] responsible for maintenance or increasing anti-oxidant capacity of T
cells could be employed to increase T-cell activity and function and effectively increase the
potential of T cells in immunotherapy.
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Figure 1. Effect of IL-15 on T cells
(A). CD8+ T cells cultured in the presence of IL-2 and IL-15 for 7 days were exposed to 25
μM of H2O2. Cells were stained for CD8 and Annexin V. Histogram represents level of
Annexin V on cells with or without H2O2 stimulation after 16 h.
(B). CD8+ T cells cultured in the presence of IL-2 and IL-15 for 7 days were evaluated for
expression of cell surface thiols using fluorochrome conjugated maleimide (ALM). Grey
histogram represents unstained, whereas black histogram represents fluorescence from
stained samples. Numerical values on right corner represent Mean Fluorescence Intensity
(MFI).
(C). Level of surface thiols on the T cells cultured for 7 days in presence of increasing dose
of IL-15 was evaluated using fluorochrome conjugated maleimide (ALM). Each histogram
represents fluorescence on cells obtained after co-culture. Data shown in A, B and C are
from one of three experiments with similar results.
Kaur et al. Page 15
Cytokine. Author manuscript; available in PMC 2013 March 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. Expression of intracellular glutathione and thioredoixn-2 in IL-2 and IL-15 cultured T
cells
(A). CD8+ T cells cultured in the presence of IL-2 and IL-15 for seven days were tested for
expression of intracellular glutathione using monochlorobimane. Histogram represents
fluorescence from stained samples.
(B). Cell lysates were prepared using CD8+ T cells cultured in the presence of IL-2 and
IL-15 for 7 days and probed for the expression of thioredoxin-2. Blots were probed with
GAPDH for loading control. Data shown in A and B are from one of three experiments with
similar results.
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Figure 3. Comparison of IL-15 and IL-2 treatment on expression of anti-apoptotic proteins and
cytokine secretion
(Ai). IL-15 and IL-2 cultured CD8+ T cells were used to determine the expression level of
anti-apoptotic proteins bcl-2 and bcl-xl. Histograms represent fluorescence intensity of
proteins after intracellular staining. Red histogram represents isotype, whereas blue and
green histogram represents fluorescence from stained samples. Numerical values on right
corner represent Mean Fluorescence Intensity (MFI).
(Aii). T cells cultured in the presence of IL-2 and IL-15 for 7 days were used to extract total
RNA and RT PCR was performed as described in Material and Methods. Expression of
bcl-2, bcl-xl, and GAPDH was assessed.
(B). T cells were expanded in the presence of IL-2 or IL-15 for 7 days. Total RNA was
isolated and mRNA expression levels of T-bet, IFN-γ and TNF-α were evaluated by RT-
PCR.
(C). Cell surface marker expression on CD8+ T cells gated population obtained from culture
maintained in IL-2 or IL-15 was determined by using fluorochrome conjugated antibodies
for CD44and CD57. Histogram represents fluorescence from stained samples. Numerical
values on right corner represent Mean Fluorescence Intensity (MFI).
(D). CD8+ T cells expanded in either in IL-2 or IL-15 was evaluated for the expression of
Granzyme A and Granzyme B. Histogram represents fluorescence from stained samples.
Data shown in A - D are from one of three experiments with similar results.
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Figure 4. Comparison of IL-15 vs. IL-2 on free radical accumulation and mitochondrial
membrane potential
(A). T cells cultured and maintained in the presence of IL-15 or IL-2 for 7 days were
evaluated for iNOS expression by RT-PCR.
(B-E). CD8+ T cells expanded and maintained in IL-2 and IL-15 were restimulated with
anti-CD3 (5μg/ml), PHA (1 μg/ml), H2O2 (100 μM) for overnight and Staurosporin for 2
hours and followed by staining with: (B) DAF to track NO; (C) DHE to track superoxide;
(D) DCFDA to track hydrogen peroxide; and (E) DiOC6 to track mitochondrial membrane
potential. Histograms represent fluorescence intensity of DAF, DHE, DCFDA and DiOC6
on the CD8+ T cells. Data shown in Figure A - D are from one of three experiments with
similar results.
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Table 1
Oxidative stress and antioxidant defense related genes analyzed by real time PCR array.
UniGene
ID
Accession
No.
Symbol Description Fold
change
Genes Up- regulated in presence of IL-15 as compared to IL-2
Hs.239 NM_021953 FOXM1 Forkhead box M1 14.25
Hs.271510 NM_000637 GSR Glutathione reductase 2.89
Hs.145932 NM_004923 MLT5 Metallothionein-like 5,
testis-specific (tesmin)
2.35
Hs.534331 NM_002452 NUDT1 Nudix (nucleoside
diphosphate linked moiety
X)-type motif 1
5.40
Hs.146100 NM_015553 IPCEF1 Interaction protein for
cytohesin exchange factors
1
3.32
Hs.180909 NM_002574 PRDX1 Peroxiredoxin 1 2.83
Hs.432121 NM_005809 PRDX2 Peroxiredoxin 2 3.25
Hs.466693 NM_012237 SIRT2 Sirtuin (silent mating type
information regulation 2
homolog) 2 (S. cerevisiae)
3.82
Hs.443914 NM_000454 SOD1 Superoxide dismutase 1,
soluble
12.41
Hs.487046 NM_000636 SOD2 Superoxide dismutase 2,
mitochondrial
9.40
Hs.708065 NM_003330 TXNRD1 Thioredoxin reductase 1 5.04
Genes Down- regulated in presence of IL-15 as compared to IL-2
Hs.95120 NM_134268 CYGB Cytoglobin −19.25
Hs.171695 NM_004417 DUSP1 Dual specificity
phosphatase 1
−11.06
Hs.458272 NM_000250 MPO Myeloperoxidase −16.76
Hs.657932 NM_024505 NOX5 NADPH oxidase, EF-hand
calcium binding domain 5
−4.19
Hs.251386 NM_006093 PRG3 Proteoglycan 3 −5.53
Hs.196384 NM_000963 PTGS2 Prostaglandin-
endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
−3.40
Hs.444882 NM_144651 PXDNL Peroxidasin homolog
(Drosophila)-like
−3.17
Hs.467554 NM_000547 TPO Thyroid peroxidase −3.17
Hs.98712 NM_032243 TXNDC2 Thioredoxin domain
containing 2 (spermatozoa)
−2.96
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